Email ID
Password
Scrip   
SkyePharma's Flutiform positive in final Phase III trial
04 November 2009
Asher Mullard

Preliminary results show that SkyePharma's asthma combination product Flutiform (fluticasone plus formoterol) was positive in its final Phase III trial, clearing the path for a planned EU filing in the first quarter of 2010.

PiperJaffray analysts commented, however, that these results may...



Please Login to read the full article.
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36